Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;18(1):16-7.
doi: 10.3747/co.v18i1.680.

Weekly paclitaxel in ovarian cancer-the latest success story

A Jain  1 , B Dubashi, K S Reddy, P Jain
Affiliations

Weekly paclitaxel in ovarian cancer-the latest success story

A Jain et al. Curr Oncol. 2011 Jan.
No abstract available

Keywords: Weekly paclitaxel; adjuvant chemotherapy; intraperitoneal chemotherapy; ovarian cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Markman M, Blessing J, Rubin SC. Phase ii trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study. Gynecol Oncol. 2006;101:436–40. doi: 10.1016/j.ygyno.2005.10.036. - DOI - PubMed
    1. Katsumata N, Yasuda M, Takahashi F, et al. on behalf of the Japanese Gynecologic Oncology Group. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. Lancet. 2009;374:1331–8. doi: 10.1016/S0140-6736(09)61157-0. - DOI - PubMed
    1. Sparano JA, Wang M, Martino S, et al. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med. 2008;358:1663–71. doi: 10.1056/NEJMoa0707056. - DOI - PMC - PubMed
    1. Rose PG, Smrekar M, Fusco N. A phase ii trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma. Gynecol Oncol. 2005;96:296–300. doi: 10.1016/j.ygyno.2004.03.046. - DOI - PubMed
    1. Bookman MA. Dose-dense chemotherapy in advanced ovarian cancer. Lancet. 2009;374:1303–5. doi: 10.1016/S0140-6736(09)61305-2. - DOI - PubMed

LinkOut - more resources